How do Super Lean Subjects Keep Resistant to Body Weight Gain?
The Investigation of Lifestyle and Genetics in Super Lean Subjects That Keep Them Resistant to Weight Gain
1 other identifier
observational
300
1 country
1
Brief Summary
Obesity is the 5th leading cause of global death, and is major risk factors for many chronic diseases, such as type 2 diabetes, cardiovascular diseases, hypertension and cancer. Obesity is caused by an imbalance between energy intake and energy expenditure, and it is widely agreed to be a consequence of a gene by environment interaction. Although on average obesity rates are increasing, the shape of the distribution of adiposity is changing: it is becoming more right skewed. This is because there is a population of very lean subjects that has remained almost unchanged by the epidemic. The investigators have called these very lean individuals that are resistant to the epidemic and sustain a BMI \< 18.5 kg/m2 'super lean' subjects. We have very little understanding of the lifestyles of these individuals and how they are able to maintain their super lean phenotype, and whether the basis of their leanness is primarily genetics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 6, 2017
CompletedFirst Submitted
Initial submission to the registry
June 27, 2017
CompletedFirst Posted
Study publicly available on registry
July 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 21, 2022
July 1, 2022
8.7 years
June 27, 2017
July 19, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Anthropometric measurements of participants in both control and superlean groups
Height, waist and hip circumferences (cm) and body composition will be measured on arrival.
Through study completion, an average of 2 years
Demographic characteristics of all participants in both control and superlean groups
Life style questionnaire filled out on arrival.
Through study completion, an average of 2 years
Study Arms (2)
Control
20 kg/m2 ≤ BMI ≤ 25 kg/m2, healthy, with no eating disorder, 150 subjects, 20 - 40 years old
Superlean
15 kg/m2 ≤ BMI ≤ 18 kg/m2, healthy, with no eating disorder, 150 subjects, 25 - 35 years old in particular
Interventions
Behavioural data will be collected on all subjects in either control group or superlean group. Blood or saliva samples will be collected for DNA extraction and genotyping.
Eligibility Criteria
Participants are healthy, with no eating disorder, 25 - 35 years old in particular.
You may qualify if:
- control: BMI 20-25 kg/m2, healthy, age 20-40 years old superlean: BMI 15-18 kg/m2, healthy, with no eating disorders and diabetes, age 20-40 years old
You may not qualify if:
- Pregnant women and women in lactation Subjects are suffering from eating disorders or diabetes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Genetics and Developmental Biology
Beijing, 100101, China
Biospecimen
9 ml of blood samples will be collected for the biological measurements and DNA extraction for genotyping.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Speakman, PhD
Institute of Genetics and Developmental Biology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 27, 2017
First Posted
July 18, 2017
Study Start
April 6, 2017
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
July 21, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share